Cited by 681Advanced Drug Delivery SystemsDrug Solubulity and Delivery SystemsProteins in Food Systems

The DOI matches its Crossref record; 217 of the 219 references it cites were found in a registry or an index.

Approaches for enhancing oral bioavailability of peptides and proteins

Open access

Renukuntla, Jwala, Vadlapudi, Aswani Dutt, Patel, Ashaben, Boddu, Sai H.S., Mitra, Ashim K.·2013·International Journal of Pharmaceutics

DOI 10.1016/j.ijpharm.2013.02.030PMC PMC3680128

Open this paper in CoChat — free account

Abstract

Oral delivery of peptide and protein drugs faces immense challenge partially due to the gastrointestinal (GI) environment. In spite of considerable efforts by industrial and academic laboratories, no major breakthrough in the effective oral delivery of polypeptides and proteins has been accomplished. Upon oral administration, gastrointestinal epithelium acts as a physical and biochemical barrier for absorption of proteins resulting in low bioavailability (typically less than 1-2%). An ideal oral drug delivery system should be capable of (a) maintaining the integrity of protein molecules until it reaches the site of absorption, (b) releasing the drug at the target absorption site, where the delivery system appends to that site by virtue of specific interaction, and (c) retaining inside the gastrointestinal tract irrespective of its transitory constraints. Various technologies have been explored to overcome the problems associated with the oral delivery of macromolecules such as insulin, gonadotropin-releasing hormones, calcitonin, human growth factor, vaccines, enkephalins, and interferons, all of which met with limited success. This review article intends to summarize the physiological barriers to oral delivery of peptides and proteins and novel pharmaceutical approaches to circumvent these barriers and enhance oral bioavailability of these macromolecules.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ijpharm.2013.02.030

Cites

217 of 217 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: In situ-forming hydrogels for sustained ophthalmic drug delivery
Nanjawade, B. K., Manvi, F. V., & Manjappa, A. S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.07.009 · Cited by 213
Retracted
Physiology of the Gastrointestinal Tract
Johnson, L. R. (2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088394-3.x5000-4 · Cited by 4,616
Hydrogels in pharmaceutical formulations
Peppas, N. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00090-4 · Cited by 4,011
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,417
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,845
In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the Mouse
Schwarze, S. R., Ho, A. L., Vocero-Akbani, A. M., & Dowdy, S. F. (1999) · Science · doi:10.1126/science.285.5433.1569 · Cited by 2,418
Pharmaceutical Applications of Cyclodextrins. 1. Drug Solubilization and Stabilization
Loftsson, Þ., & Brewster, M. E. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950534b · Cited by 2,179
Cyclodextrins as pharmaceutical solubilizers
Brewster, M. E., & Loftsson, Þ. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.012 · Cited by 1,942
Penetration enhancers
Williams, A. C., & Barry, B. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.025 · Cited by 1,746
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D.-M., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,681
Skin penetration enhancers
Lane, M. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.040 · Cited by 1,486
Principles of Anatomy and Physiology
Baker, G. F., Tortora, G. J., & Nostakos, N. P. A. (1976) · AJN American Journal of Nursing · doi:10.2307/3423898 · Cited by 1,322
Cyclodextrins in drug delivery: An updated review
Challa, R., Ahuja, A., Ali, J., & Khar, R. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060243 · Cited by 1,215
Protein drug stability: a formulation challenge
Frøkjær, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,116
Nanoparticles in cellular drug delivery
Faraji, A. H., & Wipf, P. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.02.043 · Cited by 937
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
Almeida, A. J., & Souto, E. B. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 817
Cell-penetrating peptides: mechanism and kinetics of cargo delivery
Zorko, M., & Langel, Ü. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.010 · Cited by 815
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 766
Mucoadhesive drug delivery systems
Donnelly, R. F., Shaikh, R., Singh, T. R. R., Garland, M. J., & Woolfson, A. D. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.76478 · Cited by 743
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 705
Cell-penetrating peptides: breaking through to the other side
Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 694
Biopharmaceutics and clinical pharmacokinetics
(1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90260-d · Cited by 693
Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia, M. K., & Jain, S. (2003) · PubMed · Cited by 608
Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat
Pappenheimer, J. R., & Reiss, K. Z. (1987) · The Journal of Membrane Biology · doi:10.1007/bf02209145 · Cited by 527
Oral Delivery of Peptide Drugs
Hamman, J. H., Enslin, G. M., & Kotz, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 504
Colloidal Drug Delivery Systems
Kreuter, J. (2014) · CRC Press eBooks · doi:10.1201/9781498710565 · Cited by 472
A New Approach to the Oral Administration of Insulin and Other Peptide Drugs
Saffran, M., Kumar, G. S., Savariar, C. M., Burnham, J. C., Williams, F. E., & Neckers, D. C. (1986) · Science · doi:10.1126/science.3526553 · Cited by 469
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery
Yin, L., Ding, J., He, C., Cui, L., Tang, C., & Yin, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.055 · Cited by 451
Vesicular systems in ocular drug delivery: an overview
Kaur, I. P., Garg, A. B., Singla, A. K., & Aggarwal, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.016 · Cited by 450
Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery
Yun, Y., Cho, Y. W., & Park, K. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.007 · Cited by 443
P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement
Varma, M. V. S. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00158-0 · Cited by 420
Colloidal drug delivery systems
Duncan‐Hewitt, W. C. (1995) · Colloids and Surfaces B Biointerfaces · doi:10.1016/0927-7765(95)90010-1 · Cited by 419
Oral delivery of insulin using pH‐responsive complexation gels
Lowman, A. M., Morishita, M., Kajita, M., NAGAI, T., & Peppas, N. A. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980337n · Cited by 407
Carrier-Mediated Intestinal Transport of Drugs
Tsuji, A., & Tamai, I. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086003070 · Cited by 391
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
Schipper, N. G. M., Vårum, K. M., & Artursson, P. (1996) · Pharmaceutical Research · doi:10.1023/a:1016444808000 · Cited by 384
A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery
Gratieri, T., Gelfuso, G. M., Rocha, E. M., Sarmento, V. H. V., de Freitas, O., & Lopez, R. F. V. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.02.011 · Cited by 377
Emerging Trends in Oral Delivery of Peptide and Protein Drugs
Mahato, R. I., Narang, A. S., Thoma, L. A., & Miller, D. D. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i23.30 · Cited by 357
Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties.
Peh, K. K., & Wong, C. F. (2000) · PubMed · Cited by 356
Azoreductase activity of anaerobic bacteria isolated from human intestinal microflora
Rafii, F., Franklin, W., & Cerniglia, C. E. (1990) · Applied and Environmental Microbiology · doi:10.1128/aem.56.7.2146-2151.1990 · Cited by 340
Therapeutic application of peptides and proteins: parenteral forever?
Antošová, Z., Macková, M., Král, V., & Macek, T. (2009) · Trends in biotechnology · doi:10.1016/j.tibtech.2009.07.009 · Cited by 325
Microbially triggered drug delivery to the colon
Sinha, V. R., & Kumria, R. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00221-x · Cited by 323
Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 321
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon
Tozaki, H., Komoike, J., Tada, C., Maruyama, T., Terabe, A., Suzuki, T., Yamamoto, A., & Muranishi, S. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970018g · Cited by 315
The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins
Bernkop‐Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00204-6 · Cited by 310
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2011) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
Cyclodextrins in peptide and protein delivery
Irie, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00057-x · Cited by 304
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
Oral insulin delivery by means of solid lipid nanoparticles.
Sarmento, B. F. C. C., Martins, S., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 299
Chitosans as absorption enhancers of poorly absorbable drugs
Schipper, N. G. M., Vårum, K. M., Stenberg, P., Ocklind, G., Lennernäs, H., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00032-9 · Cited by 278
Drug permeation enhancement via buccal route: possibilities and limitations
Şenel, S., & Hıncal, A. A. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00269-3 · Cited by 272
Biodegradable microparticles as controlled release antigen delivery systems.
O’Hagan, D. T., Rahman, D., McGee, J. P., Jeffery, H., Davies, M. C., Williams, P. M., Davis, S. S., & Challacombe, S. (1991) · PubMed Central · Cited by 270
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2010) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
Protein and peptide drug delivery: Oral approaches
Shaji, J., & Patole, V. (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.42967 · Cited by 265
Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies
Pauletti, G. M. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00045-8 · Cited by 234
The American Psychiatric Publishing textbook of psychopharmacology
(2010) · Choice Reviews Online · doi:10.5860/choice.47-4164 · Cited by 233
The Influence of Peptide Structure on Transport Across Caco-2 Cells
Conradi, R. A., Hilgers, A. R., Ho, N. F. H., & Burton, P. S. (1991) · Pharmaceutical Research · doi:10.1023/a:1015825912542 · Cited by 228
Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan–EDTA conjugates
Bernkop‐Schnürch, A. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00136-3 · Cited by 223
Novel Drug Delivery Systems
Banerjee, P. S., & Robinson, J. R. (1991) · Clinical Pharmacokinetics · doi:10.2165/00003088-199120010-00001 · Cited by 222
Peroral Route: An Opportunity for Protein and Peptide Drug Delivery
Sood, A., & Panchagnula, R. (2001) · Chemical Reviews · doi:10.1021/cr000700m · Cited by 222
Recent Advances in Protein and Peptide Drug Delivery Systems
Malik, D. K., Baboota, S., Ahuja, A., Hasan, S., & Ali, J. (2007) · Current Drug Delivery · doi:10.2174/156720107780362339 · Cited by 216
Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery
Su, F.-Y., Lin, K., Sonaje, K., Wey, S., Yen, T., Ho, Y., Panda, N., Chuang, E., Maiti, B., & Sung, H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.12.038 · Cited by 206
Present and future of cell-penetrating peptide mediated delivery systems: “Is the Trojan horse too wild to go only to Troy?”
Vivès, É. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.032 · Cited by 201
Chances and pitfalls of cell penetrating peptides for cellular drug delivery
Tréhin, R., & Merkle, H. P. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.02.018 · Cited by 200
Physiology of the Gastrointestinal Tract.
DeLor, C. J. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300170121031 · Cited by 192
Enhanced Oral Uptake of Tomato Lectin-Conjugated Nanoparticles in the Rat
Hussain, N., Jani, P. U., & Florence, A. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012153011884 · Cited by 190
Structures of archaebacterial membrane lipids
Sprott, G. D. (1992) · Journal of Bioenergetics and Biomembranes · doi:10.1007/bf00762348 · Cited by 189
Preactivated thiomers as mucoadhesive polymers for drug delivery
Iqbal, J., Shahnaz, G., Dünnhaupt, S., Muller, C. R., Hintzen, F., & Bernkop‐Schnürch, A. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.021 · Cited by 187
Converting Peptides into Drug Leads by Lipidation
Zhang, L., & Bulaj, G. W. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799945003 · Cited by 187
Oral delayed-release system for colonic specific delivery
Gazzaniga, A., Iamartino, P., Maffione, G., & Sangalli, M. E. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90418-9 · Cited by 184
Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery III: Oral Delivery of Chlorothiazide Using a Bioadhesive Polymer
Longer, M. A., Ch'Ng, H. S., & Robinson, J. R. (1985) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600740408 · Cited by 180
Effect of Size and Charge on the Passive Diffusion of Peptides Across Caco-2 Cell Monolayers via the Paracellular Pathway
Pauletti, G. M., Okumu, F. W., & Borchardt, R. T. (1997) · Pharmaceutical Research · doi:10.1023/a:1012040425146 · Cited by 177
Usefulness of cell-penetrating peptides to improve intestinal insulin absorption
Kamei, N., Morishita, M., Eda, Y., Ida, N., Nishio, R., & Takayama, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.001 · Cited by 177
How Structural Features Influence the Biomembrane Permeability of Peptides
Burton, P. S., Conradi, R. A., Ho, N. F. H., Hilgers, A. R., & Borchardt, R. T. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js960067d · Cited by 177
Oral biodrug delivery using cell-penetrating peptide
Khafagy, E., & Morishita, M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.014 · Cited by 174
Folate-Decorated PLGA Nanoparticles as A Rationally Designed Vehicle for The Oral Delivery of Insulin
Jain, S., Rathi, V. V., Jain, A., Das, M., & Godugu, C. (2012) · Nanomedicine · doi:10.2217/nnm.12.31 · Cited by 174
Evidence for a Polarized Efflux System in Caco-2 Cells Capable of Modulating Cyclosporine A Transport
Augustijns, P., Bradshaw, T., Gan, L., Hendren, R. W., & Thakker, D. R. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2487 · Cited by 172
Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers
Morishita, M., Lowman, A. M., Takayama, K., Nagai, T., & Peppas, N. A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00019-6 · Cited by 170
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery
García-Fuentes, M., Prego, C., Torres, D., & Alonso, M. J. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.02.008 · Cited by 170
A novel approach using functional peptides for efficient intestinal absorption of insulin
Morishita, M., Kamei, N., Ehara, J., Isowa, K., & Takayama, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.022 · Cited by 166
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat
Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Vlasov, A. P., Vorobyov, M., Kholodova, E., & Zabarovskaya, Z. V. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00579-8 · Cited by 161
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Shakweh, M., Ponchel, G., & Fattal, E. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.141 · Cited by 161
Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium
Salamat‐Miller, N., & Johnston, T. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.022 · Cited by 156
Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin–liposome nanocomplexes
Thirawong, N., Thongborisute, J., Takeuchi, H., & Sriamornsak, P. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.023 · Cited by 155
An in vitro evaluation of a chitosan-containing multiparticulate system for macromolecule delivery to the colon
Zhang, H., Alsarra, I. A., & Neau, S. H. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00112-6 · Cited by 149
Structural Specificity of Mucosal-Cell Transport and Metabolism of Peptide Drugs: Implication for Oral Peptide Drug Delivery
Bai, J. P. F., & Amidon, G. L. (1992) · Pharmaceutical Research · doi:10.1023/a:1015885823793 · Cited by 145
Evidence for a Polarized Efflux System for Peptides in the Apical Membrane of Caco-2 Cells
Burton, P. S., Conradi, R. A., Hilgers, A. R., & Ho, N. F. H. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1114 · Cited by 144
Silica nanoparticle coated liposomes: A new type of hybrid nanocapsule for proteins
Mohanraj, V. J., Barnes, T. J., & Prestidge, C. A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.061 · Cited by 142
Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
Cheng, J., Teply, B. A., Jeong, S. Y., Yim, C. H., Ho, D. C., Sherifi, I., Jon, S., Farokhzad, O. C., Khademhosseini, A., & Langer, R. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-9444-5 · Cited by 134
Controlled Release of Polypeptides and Other Macromolecules
Siegel, R. A., & Langer, R. (1984) · Pharmaceutical Research · doi:10.1023/a:1016318423563 · Cited by 133
Enhancement of Colonic Drug Absorption by the Transcellular Permeation Route
Tomita, M., Hayashi, M., Horie, T., Ishizawa, T., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015992819290 · Cited by 133
Delivery systems for penetration enhancement of peptide and protein drugs: design considerations.
Kompella, U. B., & Lee, V. H. L. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00137-x · Cited by 131
Effect of cell-penetrating peptides on the nasal absorption of insulin
Khafagy, E., Morishita, M., Isowa, K., Imai, J., & Takayama, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.076 · Cited by 130
Sodium Dependent Multivitamin Transporter (SMVT): A Potential Target for Drug Delivery
Vadlapudi, A. D., Vadlapatla, R. K., & Mitra, A. K. (2012) · Current Drug Targets · doi:10.2174/138945012800675650 · Cited by 130
Self-citation
Biodegradable microparticles for oral immunization
O’Hagan, D. T., McGee, J. P., Holmgren, J. R., Mowat, A. M., Donachie, A. M., Mills, K. H. G., Gaisford, W., Rahman, D., & Challacombe, S. (1993) · Vaccine · doi:10.1016/0264-410x(93)90011-l · Cited by 129
Plasma-treated PET surfaces improve the biocompatibility of human endothelial cells
Ramires, P. A., Mirenghi, L., Romano, A. R., Palumbo, F., & Nicolardi, G. (2000) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(20000905)51:3 · Cited by 128
The intestinal absorption of some dipeptides
Newey, H. A., & Smyth, D. H. (1959) · The Journal of Physiology · doi:10.1113/jphysiol.1959.sp006125 · Cited by 127
Oral colon delivery of insulin with the aid of functional adjuvants
Maroni, A., Zema, L., Curto, M. D. D., Foppoli, A., & Gazzaniga, A. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.10.006 · Cited by 127
Prodrug Design to Improve Pharmacokinetic and Drug Delivery Properties: Challenges to the Discovery Scientists
Jana, S., Mandlekar, S., & Marathe, P. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710793205426 · Cited by 127
Reversible lipidization for the oral delivery of salmon calcitonin
Wang, J., Chow, D. D., Heiati, H., & Shen, W. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00008-7 · Cited by 125
Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency
Liang, J. F., & Yang, V. C.-M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.142 · Cited by 124
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent
Bai, Y., Ann, D. K., & Shen, W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500062102 · Cited by 123
Oral Controlled Release Technology for Peptides: Status and Future Prospects
Fix, J. A. (1996) · Pharmaceutical Research · doi:10.1023/a:1016008419367 · Cited by 119
Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides
Kamei, N., Morishita, M., & Takayama, K. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.02.015 · Cited by 119
Noninvasive routes of proteins and peptides drug delivery.
jitendra, Sharma, P. K., Bansal, S., & Banik, A. (2011) · Europe PMC (PubMed Central) · doi:10.4103/0250-474x.95608 · Cited by 118
The potential use of receptor-mediated endocytosis for oral drug delivery
Russell-Jones, G. J. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00131-p · Cited by 115
Targeted enteral delivery of insulin to rats
Touítou, E., & Rubinstein, A. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90069-4 · Cited by 112
Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system
Bernkop‐Schnürch, A., Weithaler, A., Albrecht-Schgoer, K., & Greimel, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.044 · Cited by 109
Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport
Sharom, F. J., Yu, X., DiDiodato, G., & Chu, J. W. K. (1996) · Biochemical Journal · doi:10.1042/bj3200421 · Cited by 108
Bioadhesive interaction and hypoglycemic effect of insulin-loaded lectin–microparticle conjugates in oral insulin delivery system
Kim, B.-Y., Jeong, J. H., Park, K., & Kim, J.-D. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.032 · Cited by 108
Oral delivery of salmon calcitonin
Lee, Y.-H., & Sinko, P. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00063-6 · Cited by 108
Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems
Patel, M. M., Shah, T. J., & Amin, A. F. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i2.20 · Cited by 107
Chitosan-Coated Solid Lipid Nanoparticles for Insulin Delivery
Fonte, P., Andrade, F., Araújo, F., Andrade, C., das Neves, J., & Sarmento, B. F. C. C. (2012) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-391860-4.00015-x · Cited by 106
In vitro assessment of archaeosome stability for developing oral delivery systems
Patel, G. B., Agnew, B. J., Deschatelets, L., Fleming, L. P., & Sprott, G. D. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00331-2 · Cited by 104
Oral bioavailability and first-pass effects.
Kwan, K. C. (1997) · PubMed · Cited by 104
From sticky stuff to sweet receptors — achievements, limits and novel approaches to bioadhesion
Lehr, C. (1996) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190262 · Cited by 103
Intestinal mucosal transport of insulin
Schilling, R. J., & Mitra, A. K. (1990) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(90)90030-8 · Cited by 99
Self-citation
Developments in the area of bioadhesive drug delivery systems
Lehr, C., & Haas, J. (2002) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2.3.287 · Cited by 98
Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers
Liu, D.-Z., LeCluyse, E. L., & Thakker, D. R. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990094e · Cited by 96
Control of Postprandial Plasma Glucose by an Oral Insulin Product (HIM2) in Patients With Type 2 Diabetes
Kipnes, M. S., Dandona, P., Tripathy, D., Still, J., & Kosutic, G. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.421 · Cited by 96
Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins
Khafagy, E., Morishita, M., Kamei, N., Eda, Y., Ikeno, Y., & Takayama, K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.022 · Cited by 94
In Vivo Evaluation of an Oral Salmon Calcitonin-Delivery System Based on a Thiolated Chitosan Carrier Matrix
Guggi, D., Kast, C. E., & Bernkop‐Schnürch, A. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008047.82334.7d · Cited by 93
Enhancement of Colonic Drug Absorption by the Paracellular Permeation Route
Tomita, M., Shiga, M., Hayashi, M., & Awazu, S. (1988) · Pharmaceutical Research · doi:10.1023/a:1015999309353 · Cited by 93
Novel complexation hydrogels for oral peptide delivery: In vitro evaluation of their cytocompatibility and insulin‐transport enhancing effects using Caco‐2 cell monolayers
Ichikawa, H., & Peppas, N. A. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10128 · Cited by 91
Crosslinking Studies in Gelatin Capsules Treated with Formaldehyde and in Capsules Exposed to Elevated Temperature and Humidity
Ofner, C. M., Zhang, Y., Jobeck, V. C., & Bowman, B. J. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200101)90:1 · Cited by 90
Azo compounds in colon-specific drug delivery
Roldo, M., Barbu, E., Brown, J. F., Laight, D. W., Smart, J. D., & Tsibouklis, J. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.5.547 · Cited by 90
Oral Delivery of Biologically Active Parathyroid Hormone
Leone‐Bay, A., Sato, M., Paton, D. R., Hunt, A. H., Sarubbi, D., Carozza, M., Chou, J., McDonough, J., & Baughman, R. (2001) · Pharmaceutical Research · doi:10.1023/a:1010936227570 · Cited by 87
INTESTINAL ABSORPTION OF INSULIN IN THE RAT
Danforth, E., & MOORE, R. O. (1959) · Endocrinology · doi:10.1210/endo-65-1-118 · Cited by 84
Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2
Clement, S. C., Still, J., Kosutic, G., & McAllister, R. G. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502760306544 · Cited by 84
The absorption of insulin from various regions of the rat intestine
Kidron, M., Bar-On, H., Berry, E. M., & Ziv, E. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90673-7 · Cited by 84
Cyclodextrins as Mucosal Absorption Promoters of Insulin. II. Effects of β-Cyclodextrin Derivatives on α-Chymotryptic Degradation and Enteral Absorption of Insulin in Rats
Shao, Z., Li, Y., Chermak, T., & Mitra, A. K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018997101542 · Cited by 83
Self-citation
Investigation of archaeosomes as carriers for oral delivery of peptides
Li, Z., Chen, J., Sun, W., & Xu, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.041 · Cited by 82
Chitosan: a potential polymer for colon-specific drug delivery system
Gulbake, A., & Jain, S. K. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.682148 · Cited by 81
pH‐Sensitive Hydrogels as Gastrointestinal Tract Absorption Enhancers: Transport Mechanisms of Salmon Calcitonin and Other Model Molecules Using the Caco‐2 Cell Model
Torres‐Lugo, M., García-Fuentes, M., Record, R. D., & Peppas, N. A. (2002) · Biotechnology Progress · doi:10.1021/bp0101379 · Cited by 81
Complexation hydrogels for intestinal delivery of interferon β and calcitonin
Kamei, N., Morishita, M., Chiba, H., Kavimandan, N. J., Peppas, N. A., & Takayama, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.11.014 · Cited by 80
Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin
Builders, P. F., Kunle, O. O., Okpaku, L. C., Builders, M. I., Attama, A. A., & Adikwu, M. U. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.021 · Cited by 80
Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.
Hurni, M. A., Noach, A. B. J., Blom-Roosemalen, M. C. M., Boer, A. G. D., Nagelkerke, J. F., & Breimer, D. D. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39367-5 · Cited by 80
Oral Colon-Specific Drug Delivery of Protein and Peptide Drugs
Sinha, V. R., Singh, A., Kumar, R. V., Singh, S. K., Kumria, R., & Bhinge, J. R. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i1.30 · Cited by 79
Improvement of Large Intestinal Absorption of Insulin by Chemical Modification with Palmitic Acid in Rats
Hashizume, M., Douen, T., Murakami, M., Yamamoto, A., Takada, K., & Muranishi, S. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05463.x · Cited by 79
The potential use of receptor-mediated endocytosis for oral drug delivery1PII of original article: S0169_409X(96)00334-1. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 83–97.1
Russell-Jones, G. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00127-7 · Cited by 76
Mechanistic studies on the uptake and intracellular trafficking of novel cyclodextrin transfection complexes by intestinal epithelial cells
Neill, M. J. O., Guo, J., Byrne, C. J., Darcy, R., & O’Driscoll, C. M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.04.021 · Cited by 75
Optimizing oral absorption of peptides using prodrug strategies
Borchardt, R. T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00042-5 · Cited by 74
Eudragit RS 100 microparticles containing 2-hydroxypropyl-β-cyclodextrin and glutathione: Physicochemical characterization, drug release and transport studies
Trapani, A., Laquintana, V., Denora, N., Lopedota, A. A., Cutrignelli, A., Franco, M., Trapani, G., & Liso, G. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.10.003 · Cited by 72
Polysaccharides: a targeting strategy for colonic drug delivery
Shah, N., Shah, T. J., & Amin, A. F. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.574121 · Cited by 72
Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles
Yuan, H., Jiang, S., Du, Y., Miao, J., Zhang, X., & Hu, F. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.12.031 · Cited by 71
Colon Targeted Drug Delivery Systems -An Overview
Kumar, P., & Mishra, B. (2008) · Current Drug Delivery · doi:10.2174/156720108784911712 · Cited by 70
Critical review and synthesis of the epidemiologic evidence on formaldehyde exposure and risk of leukemia and other lymphohematopoietic malignancies
Checkoway, H., Boffetta, P., Mundt, D. J., & Mundt, K. A. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0055-2 · Cited by 69
Use of Targeting Agents to Increase Uptake and Localization of Drugs to the Intestinal Epithelium
Russell-Jones, G. J. (2004) · Journal of drug targeting · doi:10.1080/10611860410001693760 · Cited by 66
Contribution of Cholesterol and Phospholipids to Inhibitory Effect of Dimethyl-β-Cyclodextrin on Efflux Function of P-Glycoprotein and Multidrug Resistance-Associated Protein 2 in Vinblastine-Resistant Caco-2 Cell Monolayers
Arima, H., Yunomae, K., Morikawa, T., Hirayama, F., & Uekama, K. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022409.27896.d4 · Cited by 64
Current Prodrug Design for Drug Discovery
Hsieh, P., Hung, C., & Fang, J. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788682523 · Cited by 64
Effect of cell-penetrating peptide-coated nanostructured lipid carriers on the oral absorption of tripterine
Yuan, L., Zhang, Z., Wei, C., Zhou, L., Wu, Q., & Chen (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34991 · Cited by 62
Novel approaches for retinal drug delivery
Kurz, D. E., & Ciulla, T. A. (2002) · Ophthalmology Clinics of North America · doi:10.1016/s0896-1549(02)00034-2 · Cited by 61
Use of fluorescence imaging to investigate the structure and function of intestinal M cells
BUDA, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.014 · Cited by 59
Effect of Trypsin Inhibitor on Passage of Insulin Across the Intestinal Barrier
Laskowski, M. C., Haessler, H. A., Miech, R. P., Peanasky, R. J., & Laskowski, M. C. (1958) · Science · doi:10.1126/science.127.3306.1115 · Cited by 58
Role of efflux pumps and metabolising enzymes in drug delivery
Katragadda, S., Budda, B., Anand, B. S., & Mitra, A. K. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.4.683 · Cited by 58
Self-citation
Enhanced transbuccal salmon calcitonin (sCT) delivery: Effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation
Oh, D.-H., Chun, K.-H., Jeon, S.-O., Kang, J. W., & Lee, S. K. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.05.010 · Cited by 58
Preparation and Characterization of Mono-PEGylated Epidermal Growth Factor: Evaluation of in Vitro Biologic Activity
Lee, H., & Park, T. G. (2002) · Pharmaceutical Research · doi:10.1023/a:1016113117851 · Cited by 57
Thiomers for oral delivery of hydrophilic macromolecular drugs
Bernkop‐Schnürch, A., Hoffer, M. H., & Kafedjiiski, K. (2004) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.1.1.87 · Cited by 57
Targeted lipid based drug conjugates: A novel strategy for drug delivery
Vadlapudi, A. D., Vadlapatla, R. K., Kwatra, D., Earla, R., Samanta, S., Pal, D., & Mitra, A. K. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.033 · Cited by 57
Self-citation
Archaeosomes varying in lipid composition differ in receptor‐mediated endocytosis and differentially adjuvant immune responses to entrapped antigen
Sprott, G. D., Sad, S., Fleming, L. P., Dicaire, C. J., Patel, G. B., & Krishnan, L. (2002) · Archaea · doi:10.1155/2003/569283 · Cited by 56
A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
Yamamoto, A., Hayakawa, E., Kato, Y., Nishiura, A., & Lee, V. H. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10333-9 · Cited by 55
Cutting-edge technologies in colon-targeted drug delivery systems
Patel, M. M. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.597739 · Cited by 54
WATCHING PEPTIDE DRUGS GROW UP
(2005) · Chemical & Engineering News · doi:10.1021/cen-v083n011.p017 · Cited by 54
Cyclodextrins — Useful excipients for oral peptide administration?
Haeberlin, B., Gengenbacher, T., Meinzer, A., & Fricker, G. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04499-7 · Cited by 52
Passive Transepithelial Absorption of Thyrotropin-Releasing Hormone (TRH) via a Paracellular Route in Cultured Intestinal and Renal Epithelial Cell Lines
Thwaites, D. T., Hirst, B. H., & Simmons, N. L. (1993) · Pharmaceutical Research · doi:10.1023/a:1018947430018 · Cited by 51
Reversible lipidization for the oral delivery of leu-enkephalin
Wang, J., Hogenkamp, D. J., Tran, M. B., Li, W.-Y., Yoshimura, R. F., Johnstone, T. B. C., Shen, W., & Gee, K. W. (2006) · Journal of drug targeting · doi:10.1080/10611860600648221 · Cited by 51
The effect of additives on the oral mucosal absorption of human calcitonin in rats.
Nakada, Y., AWATA, N., NAKAMICHI, C., & SUGIMOTO, I. (1988) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.11.395 · Cited by 49
The Effects of Backing Materials and Multilayered Systems on the Characteristics of Bioadhesive Buccal Patches
Guo, J., & Cooklock, K. M. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05912.x · Cited by 48
In vitrointestinal transport of vasopressin and its analogues
Vilhardt, H., & LUNDIN, S. (1986) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1986.tb07861.x · Cited by 47
Oral Delivery System for Two-pulse Colonic Release of Protein Drugs and Protease Inhibitor/Absorption Enhancer Compounds
Curto, M. D. D., Maroni, A., Palugan, L., Zema, L., Gazzaniga, A., & Sangalli, M. E. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22560 · Cited by 47
ANTIDIURETIC ACTION OF 1-DEAMINO-[8-D-ARGININE]-VASOPRESSIN IN UNANESTHETIZED RATS
Vávra, I., Machová, A., & Krejčı́, I. (1974) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29745-2 · Cited by 47
Oral Drug Delivery and Delivery Systems
(1991) · Drugs and the pharmaceutical sciences · doi:10.1201/b14196-4 · Cited by 47
In Vivo Absorption Studies of Insulin from an Oral Delivery System
N Jerry, Y. A. (2001) · Drug Delivery · doi:10.1080/107175401300002711 · Cited by 45
Synthesis, Characterization and In Vivo Efficacy of PEGylated Insulin for Oral Delivery with Complexation Hydrogels
Tuesca, A. D., Reiff, C. M., Joseph, J. I., & Lowman, A. M. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9816-8 · Cited by 43
Preactivated thiomers: Permeation enhancing properties
Wang, X., Iqbal, J., Rahmat, D., & Bernkop‐Schnürch, A. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.045 · Cited by 43
Modified bile acids as carriers for peptides and drugs
Kramer, W., Wess, G., Enhsen, A., Falk, E., Hoffmann, A., Neckermann, G., Schubert, G., & Urmann, M. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01599-4 · Cited by 43
Anatomy and physiology of the gastrointestinal tract
Graaff, K. M. V. D. (1986) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198601001-00005 · Cited by 42
Principles of Pharmacokinetics and Pharmacodynamics
DeVane, C. L. (2009) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781585623860.as08 · Cited by 41
Effects of Polyacrylic Polymers on the Degradation of Insulin and Peptide Drugs by Chymotrypsin and Trypsin
Bai, J. P. F., Chang, L. L., & Guo, J. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05869.x · Cited by 40
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs
Lim, C.-J., & Shen, W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.001 · Cited by 39
Development of New Lipophilic Derivatives of Tetragastrin: Physicochemical Characteristics and Intestinal Absorption of Acyl-tetragastrin Derivatives in Rats
Tenma, T., Yodoya, E., Tashima, S., Fujita, T., Murakami, M., Yamamoto, A., & Muranishi, S. (1993) · Pharmaceutical Research · doi:10.1023/a:1018983511247 · Cited by 38
Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial Cells
Jaehde, U., Masereeuw, R., Boer, A. G. D., Fricker, G., Nagelkerke, J. F., Vonderscher, J., & Breimer, D. D. (1994) · Pharmaceutical Research · doi:10.1023/a:1018929508018 · Cited by 37
Influence of polyunsaturated fatty acids on Cortisol transport through MDCK and MDCK-MDR1 cells as blood–brain barrier in vitro model
Navarro, C., González‐Álvarez, I., González‐Álvarez, M., Manku, M. S., Merino, V., Casabó, V. G., & Bermejo, M. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.12.005 · Cited by 37
The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery
Millotti, G., Perera, G., Vigl, C., Pickl, K. E., Sinner, F. M., & Bernkop‐Schnürch, A. (2010) · Drug Delivery · doi:10.3109/10717544.2010.522611 · Cited by 37
The Use of Cyclodextrins Nanoparticles for Oral Delivery
Kanwar, J. R., Long, B. M., & Kanwar, J. R. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795656243 · Cited by 37
Intestinal Permeability Enhancement: Structure-Activity and Structure-Toxicity Relationships for Nonylphenoxypolyoxyethylene Surfactant Permeability Enhancers
Swenson, E. S., Milisen, W. B., & Curatolo, W. J. (1994) · Pharmaceutical Research · doi:10.1023/a:1018920728800 · Cited by 36
Modulation of Intestinal Permeability: An Innovative Method of Oral Drug Delivery for the Treatment of Inherited and Acquired Human Diseases
Fasano, A. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2667 · Cited by 36
In vitro effects of long-chain acylcarnitines on the permeability, transepithelial electrical resistance and morphology of rat colonic mucosa.
LeCluyse, E. L., Sutton, S. C., & Fix, J. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38218-2 · Cited by 35
Insulin-loaded poly(acrylic acid)-cysteine nanoparticles: Stability studies towards digestive enzymes of the intestine
Perera, G., Greindl, M., Palmberger, T. F., & Bernkop‐Schnürch, A. (2009) · Drug Delivery · doi:10.1080/10717540902937471 · Cited by 31
A preliminary study of corneal penetration of125l‐labelled idoxuridine liposome
Dharma, S. K., Fishman, P. H., & Peyman, G. A. (1986) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.1986.tb06923.x · Cited by 31
Mediation of trypsin inhibitor-induced pancreatic hypersecretion by secretin and cholecystokinin in rats
Watanabe, S., Takeuchi, T., & Chey, W. Y. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90111-b · Cited by 30
A Comparison of Thyrotropin-Releasing Hormone with Analogs: Influence of Disposition upon Pharmacology
Hichens, M. (1983) · Drug Metabolism Reviews · doi:10.3109/03602538308991382 · Cited by 30
Effects of sodium salicylate on epithelial cells of the rectal mucosa of the rat: A light and electron microscopic study
Sithigorngul, P., Burton, P. R., Nishihata, T., & Caldwell, L. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90656-2 · Cited by 30
Oral Protein Delivery: A Patent Review of Academic and Industrial Approaches
Werle, M., Makhlof, A., & Takeuchi, H. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109788452221 · Cited by 30
Research Highlights: Highlights From The Latest Articles in Nanomedicine
Rubinstein, I. (2012) · Nanomedicine · doi:10.2217/nnm.12.38 · Cited by 30
In vitroevaluation of chondroitin sulphate-chitosan microspheres as carrier for the delivery of proteins
Maculotti, K., Tira, M. E., Sonaggere, M., Perugini, P., Conti, B., Modena, T., & Pavanetto, F. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802485725 · Cited by 29
Functional expression of human P‐glycoprotein in Schizosaccharomyces pombe
Ueda, K., Shimabuku, A. M., Konishi, H., Fujii, Y., Takebe, S., Nishi, K., Yoshida, M., Beppu, T., & Komano, T. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80888-2 · Cited by 29
Colon-specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives in rats
Fetih, G. N., Fausia, H., Okada, N., Fujita, T., Attia, M., & Yamamoto, A. (2006) · Journal of drug targeting · doi:10.1080/10611860600648494 · Cited by 27
Amino-acids, Peptides, and Proteins
(1974) · Royal Society of Chemistry eBooks · doi:10.1039/9781847557292 · Cited by 23
Poly(L-lysine) as a model drug macromolecule with which to investigate secondary structure and microporous membrane transport, part 2: diffusion studies
Chittchang, M., Salamat‐Miller, N., Alur, H. H., VanderVelde, D. G., Mitra, A. K., & Johnston, T. P. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702108 · Cited by 23
Self-citation
Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery
Hauptstein, S., & Bernkop‐Schnürch, A. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.697893 · Cited by 23

Research works printed but not linked: 3

Gangurde, 2011, Approaches for peptides and proteins by colon specific delivery: Review, Int. J. Pharm. Frontier Res., 1, 110
Vinay Kumar, 2011, Colon targeting drug delivery system: A review on recent approaches, Int. J. Pharm. Biomed. Sci., 2, 11
Yang, H.P.A. (CA), Nguyen, Vu Anh (San Jose, CA), Dong, Liang C. (Mountain View, CA), Wong, Patrick S. L. (Palo Alto, CA), 1999. Peptide Formulation, in: States, U. (Ed.). Alza Corporation (Palo Alto, CA).

Sorted by citations

Basics and Recent Advances in Peptide and Protein Drug Delivery
Bruno, B. J., Miller, G. D., & Lim, C. S. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.104 · Cited by 771
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles
Elmowafy, E. M., Tiboni, M., & Soliman, M. E. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00439-x · Cited by 642
Physicochemical properties of mucus and their impact on transmucosal drug delivery
Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 544
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J. S., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 551

See all 681

Authors: Renukuntla, J., Vadlapudi, A. D., Patel, A., Boddu, S. H. S., & Mitra, A. K.
Affiliations: South College (US)
University of Missouri–Kansas City (US)
University of Toledo (US)
Corresponding author: Mitra, Ashim K.
ORCID: Vadlapudi, Aswani Dutt
Boddu, Sai H.S.
Venue: International Journal of Pharmaceutics
Publisher: Elsevier BV
Published: 2013-04
Volume: 447
Issue: 1-2
Pages: 75-93
ISSN: 0378-5173 (ISSN-L)
DOI: 10.1016/j.ijpharm.2013.02.030
PMC: PMC3680128
OpenAlex: W2008173042
Cited by: 681
References: 219
Citations by year: 2026: 37 · 2025: 55 · 2024: 47 · 2023: 55 · 2022: 67 · 2021: 40 · 2020: 67 · 2019: 55 · 2018: 61 · 2017: 63 · 2016: 49 · 2015: 37 · 2014: 34 · 2013: 11
FWCI: 5.50
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: International Journal of Pharmaceutics (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: NIH (R01 GM064320-03, R01EY09171, R01EY010659, R01 AI071199-01A2)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
Life Sciences › Agricultural and Biological Sciences › Food Science › Proteins in Food Systems
Keywords: oral bioavailability, gastrointestinal barrier, protein stability, drug absorption, peptide delivery, insulin, gonadotropin-releasing hormone, vaccines, interferon, enkephalin, growth factors
MeSH terms: Administration, Oral, Animals, Biological Availability, Chemistry, Pharmaceutical, Humans, Intestinal Absorption, Peptides, Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Approaches for enhancing oral bioavailability of peptides and proteins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks